# Consequence of Lifetime Isolated Growth Hormone Deficiency

> **NCT00149708** · NA · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 400 (estimated)

## Conditions studied

- Growth Hormone Deficiency

## Interventions

- **DRUG:** growth hormone administration for 6 months

## Key facts

- **NCT ID:** NCT00149708
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2010-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00149708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00149708, "Consequence of Lifetime Isolated Growth Hormone Deficiency". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00149708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*